25 XP   0   0   10

enVVeno Medical Corp
Buy, Hold or Sell?

Let's analyse Envveno together

PenkeI guess you are interested in enVVeno Medical Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of enVVeno Medical Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about enVVeno Medical Corp

I send you an email if I find something interesting about enVVeno Medical Corp.

Quick analysis of Envveno (30 sec.)










What can you expect buying and holding a share of Envveno? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.47
Expected worth in 1 year
$4.03
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$0.56
Return On Investment
11.4%

For what price can you sell your share?

Current Price per Share
$4.91
Expected price per share
$3.8 - $5.43
How sure are you?
50%

1. Valuation of Envveno (5 min.)




Live pricePrice per Share (EOD)

$4.91

Intrinsic Value Per Share

$-16.99 - $-19.95

Total Value Per Share

$-13.52 - $-16.49

2. Growth of Envveno (5 min.)




Is Envveno growing?

Current yearPrevious yearGrowGrow %
How rich?$46.2m$44.8m-$11.3m-33.7%

How much money is Envveno making?

Current yearPrevious yearGrowGrow %
Making money-$5.6m-$6m$352.7k6.2%
Net Profit Margin-171.4%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Envveno (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#174 / 336

Most Revenue
#294 / 336

Most Profit
#233 / 336

Most Efficient
#266 / 336

What can you expect buying and holding a share of Envveno? (5 min.)

Welcome investor! Envveno's management wants to use your money to grow the business. In return you get a share of Envveno.

What can you expect buying and holding a share of Envveno?

First you should know what it really means to hold a share of Envveno. And how you can make/lose money.

Speculation

The Price per Share of Envveno is $4.91. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Envveno.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Envveno, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.47. Based on the TTM, the Book Value Change Per Share is $0.14 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Envveno.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.42-8.6%-0.43-8.7%-0.46-9.4%-0.31-6.2%-0.26-5.3%
Usd Book Value Change Per Share1.6032.6%0.142.9%-0.29-6.0%0.173.4%0.122.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.6032.6%0.142.9%-0.29-6.0%0.173.4%0.122.4%
Usd Price Per Share5.14-4.57-5.38-4.20-3.07-
Price to Earnings Ratio-3.03--2.74--2.98--3.65--2.81-
Price-to-Total Gains Ratio3.22--9.12--19.20--4.34--5.68-
Price to Book Ratio1.48-1.90-1.61--9.68--5.44-
Price-to-Total Gains Ratio3.22--9.12--19.20--4.34--5.68-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.91
Number of shares203
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.140.17
Usd Total Gains Per Share0.140.17
Gains per Quarter (203 shares)28.4733.66
Gains per Year (203 shares)113.89134.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101141040135125
202282180269260
303423320404395
404564460539530
505695600673665
606836740808800
707977880943935
80911902010771070
9010251016012121205
10011391130013461340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.030.00.00.0%0.030.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%8.012.00.040.0%9.019.02.030.0%9.019.02.030.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.030.00.0%0.00.030.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%8.012.00.040.0%9.019.02.030.0%9.019.02.030.0%

Fundamentals of Envveno

About enVVeno Medical Corp

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Fundamental data was last updated by Penke on 2024-04-21 23:56:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of enVVeno Medical Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Envveno earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Envveno to the Medical Devices industry mean.
  • A Net Profit Margin of -685.6% means that $-6.86 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of enVVeno Medical Corp:

  • The MRQ is -685.6%. The company is making a huge loss. -2
  • The TTM is -171.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-685.6%TTM-171.4%-514.2%
TTM-171.4%YOY--171.4%
TTM-171.4%5Y-986.1%+814.7%
5Y-986.1%10Y-2,167.8%+1,181.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-685.6%-11.2%-674.4%
TTM-171.4%-18.9%-152.5%
YOY--13.9%+13.9%
5Y-986.1%-21.0%-965.1%
10Y-2,167.8%-24.6%-2,143.2%
1.1.2. Return on Assets

Shows how efficient Envveno is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Envveno to the Medical Devices industry mean.
  • -11.6% Return on Assets means that Envveno generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of enVVeno Medical Corp:

  • The MRQ is -11.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.6%TTM-16.2%+4.6%
TTM-16.2%YOY-12.8%-3.5%
TTM-16.2%5Y-22.8%+6.6%
5Y-22.8%10Y-41.8%+19.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.6%-4.0%-7.6%
TTM-16.2%-4.6%-11.6%
YOY-12.8%-4.4%-8.4%
5Y-22.8%-3.9%-18.9%
10Y-41.8%-4.9%-36.9%
1.1.3. Return on Equity

Shows how efficient Envveno is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Envveno to the Medical Devices industry mean.
  • -12.2% Return on Equity means Envveno generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of enVVeno Medical Corp:

  • The MRQ is -12.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-17.8%+5.6%
TTM-17.8%YOY-13.6%-4.2%
TTM-17.8%5Y-54.4%+36.6%
5Y-54.4%10Y-44.2%-10.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-4.1%-8.1%
TTM-17.8%-5.7%-12.1%
YOY-13.6%-5.5%-8.1%
5Y-54.4%-6.0%-48.4%
10Y-44.2%-6.9%-37.3%

1.2. Operating Efficiency of enVVeno Medical Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Envveno is operating .

  • Measures how much profit Envveno makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Envveno to the Medical Devices industry mean.
  • An Operating Margin of -761.9% means the company generated $-7.62  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of enVVeno Medical Corp:

  • The MRQ is -761.9%. The company is operating very inefficient. -2
  • The TTM is -190.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-761.9%TTM-190.5%-571.4%
TTM-190.5%YOY--190.5%
TTM-190.5%5Y-955.4%+765.0%
5Y-955.4%10Y-2,208.2%+1,252.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-761.9%-24.1%-737.8%
TTM-190.5%-16.7%-173.8%
YOY--12.5%+12.5%
5Y-955.4%-19.0%-936.4%
10Y-2,208.2%-23.8%-2,184.4%
1.2.2. Operating Ratio

Measures how efficient Envveno is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 7.62 means that the operating costs are $7.62 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of enVVeno Medical Corp:

  • The MRQ is 7.619. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.905. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ7.619TTM1.905+5.714
TTM1.905YOY-+1.905
TTM1.9055Y9.618-7.713
5Y9.61810Y16.513-6.894
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.6191.431+6.188
TTM1.9051.426+0.479
YOY-1.435-1.435
5Y9.6181.436+8.182
10Y16.5131.373+15.140

1.3. Liquidity of enVVeno Medical Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Envveno is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 34.23 means the company has $34.23 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of enVVeno Medical Corp:

  • The MRQ is 34.225. The company is very able to pay all its short-term debts. +2
  • The TTM is 22.820. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ34.225TTM22.820+11.406
TTM22.820YOY29.614-6.794
TTM22.8205Y18.169+4.651
5Y18.16910Y12.345+5.824
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ34.2252.726+31.499
TTM22.8202.732+20.088
YOY29.6143.496+26.118
5Y18.1693.560+14.609
10Y12.3453.507+8.838
1.3.2. Quick Ratio

Measures if Envveno is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Envveno to the Medical Devices industry mean.
  • A Quick Ratio of 65.06 means the company can pay off $65.06 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of enVVeno Medical Corp:

  • The MRQ is 65.065. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 42.780. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ65.065TTM42.780+22.285
TTM42.780YOY46.106-3.325
TTM42.7805Y25.378+17.402
5Y25.37810Y17.140+8.238
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ65.0651.527+63.538
TTM42.7801.645+41.135
YOY46.1062.113+43.993
5Y25.3782.289+23.089
10Y17.1402.245+14.895

1.4. Solvency of enVVeno Medical Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Envveno assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Envveno to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.05 means that Envveno assets are financed with 5.0% credit (debt) and the remaining percentage (100% - 5.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of enVVeno Medical Corp:

  • The MRQ is 0.050. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.083. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.050TTM0.083-0.033
TTM0.083YOY0.063+0.020
TTM0.0835Y0.265-0.182
5Y0.26510Y1.191-0.925
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0500.393-0.343
TTM0.0830.386-0.303
YOY0.0630.337-0.274
5Y0.2650.442-0.177
10Y1.1910.461+0.730
1.4.2. Debt to Equity Ratio

Measures if Envveno is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Envveno to the Medical Devices industry mean.
  • A Debt to Equity ratio of 5.3% means that company has $0.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of enVVeno Medical Corp:

  • The MRQ is 0.053. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.092. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.053TTM0.092-0.039
TTM0.092YOY0.068+0.024
TTM0.0925Y0.783-0.692
5Y0.78310Y0.584+0.200
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0530.560-0.507
TTM0.0920.560-0.468
YOY0.0680.479-0.411
5Y0.7830.625+0.158
10Y0.5840.676-0.092

2. Market Valuation of enVVeno Medical Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Envveno generates.

  • Above 15 is considered overpriced but always compare Envveno to the Medical Devices industry mean.
  • A PE ratio of -3.03 means the investor is paying $-3.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of enVVeno Medical Corp:

  • The EOD is -2.894. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.029. Based on the earnings, the company is expensive. -2
  • The TTM is -2.743. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.894MRQ-3.029+0.136
MRQ-3.029TTM-2.743-0.287
TTM-2.743YOY-2.984+0.242
TTM-2.7435Y-3.652+0.909
5Y-3.65210Y-2.812-0.840
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.894-0.992-1.902
MRQ-3.029-1.592-1.437
TTM-2.743-2.128-0.615
YOY-2.984-2.756-0.228
5Y-3.652-2.086-1.566
10Y-2.812-1.490-1.322
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of enVVeno Medical Corp:

  • The EOD is -3.284. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.438. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.245. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.284MRQ-3.438+0.154
MRQ-3.438TTM-3.245-0.194
TTM-3.245YOY-4.615+1.370
TTM-3.2455Y-4.429+1.184
5Y-4.42910Y-3.505-0.924
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.284-0.936-2.348
MRQ-3.438-1.487-1.951
TTM-3.245-2.933-0.312
YOY-4.615-6.215+1.600
5Y-4.429-4.622+0.193
10Y-3.505-4.718+1.213
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Envveno is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.48 means the investor is paying $1.48 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of enVVeno Medical Corp:

  • The EOD is 1.415. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.482. Based on the equity, the company is underpriced. +1
  • The TTM is 1.903. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.415MRQ1.482-0.066
MRQ1.482TTM1.903-0.421
TTM1.903YOY1.612+0.291
TTM1.9035Y-9.682+11.585
5Y-9.68210Y-5.436-4.246
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.4151.923-0.508
MRQ1.4822.377-0.895
TTM1.9032.451-0.548
YOY1.6123.215-1.603
5Y-9.6823.862-13.544
10Y-5.4364.187-9.623
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of enVVeno Medical Corp.

3.1. Institutions holding enVVeno Medical Corp

Institutions are holding 35.04% of the shares of enVVeno Medical Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Nantahala Capital Management, LLC10.60780.2172141263814126380
2023-12-31Kingdon Capital Management LLC6.29540.27838360619180282.4984
2023-12-31Perceptive Advisors LLC4.68060.0715623315-158300-20.2529
2023-12-31Armistice Capital, LLC3.2740.03064360004360000
2023-12-31Altium Capital Management, LP2.58671.2023444713444710
2023-12-31Vanguard Group Inc2.526103364056080.1811
2023-12-31Rosalind Advisors, Inc.2.34361.32123120913120910
2023-12-31UBS O'Connor LLC1.77450.0874236308100004.4188
2023-12-31Velan Capital Investment Management LP1.29330.51671722351722350
2023-12-31Geode Capital Management, LLC0.9170.00011221162940931.7225
2023-12-31Morgan Stanley - Brokerage Accounts0.45460605451723139.7816
2023-12-31BlackRock Inc0.2864038141706222.7227
2023-12-31Northern Trust Corp0.281803752620452119.7845
2023-12-31State Street Corporation0.199702660000
2024-03-31Fermata Advisors, LLC0.17420.028423198687342.1011
2023-12-31Susquehanna International Group, LLP0.1402018670-40356-68.3699
2023-12-31Dimensional Fund Advisors, Inc.0.1375018305-4-0.0218
2023-12-31Marshall Wace Asset Management Ltd0.11490.000115300153000
2023-12-31Arthur M. Cohen & Associates LLC0.10510.01691400000
2023-12-31Tamar Securities, LLC0.10510.01411399000
Total 38.29853.77625100214+3204890+62.8%

3.2. Funds holding enVVeno Medical Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.14290.000241853600
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr1.05870.00071409852461821.1555
2024-02-29Fidelity Extended Market Index0.51440.001168501-332-0.4823
2024-03-28iShares Micro-Cap ETF0.16180.01282154700
2024-02-29Fidelity Nasdaq Composite Index0.15380.00082048700
2024-02-29Fidelity Total Market Index0.14990.00011995900
2024-02-29Fidelity Series Total Market Index0.12210.00021625900
2023-09-30BlackRock Extended Mkt Composite0.10290.00051370800
2024-03-31BlackRock Extended Equity Market K0.08980.00051196340.0334
2024-03-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.08790.00021171000
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.08790.000211710-205288-94.6036
2023-12-31Northern Trust Extended Eq Market Idx0.08390.00111171337843.3466
2024-03-31NT Ext Equity Mkt Idx Fd - L0.08390.0011117100
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06450.0007858400
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05180.00076894130.1889
2024-02-29Spartan Total Market Index Pool E0.04870.0001648400
2023-12-31SSgA U.S. Extended Market Index Class I0.04210.0011560000
2024-02-29DFA US Core Equity 1 I0.03260.0001434800
2024-03-31State St US Extended Mkt Indx NL Cl C0.0270.001360000
2024-02-29DFA US Core Equity 2 I0.02350.0001313300
Total 6.13010.0231816350-177607-21.8%

3.3. Insider Transactions

Insiders are holding 0.385% of the shares of enVVeno Medical Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-13Hamed AlaviSELL83346.22

4. Summary

4.1. Key Performance Indicators

The key performance indicators of enVVeno Medical Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.5980.140+1040%-0.294+118%0.166+864%0.116+1282%
Book Value Per Share--3.4692.517+38%3.366+3%2.003+73%1.236+181%
Current Ratio--34.22522.820+50%29.614+16%18.169+88%12.345+177%
Debt To Asset Ratio--0.0500.083-40%0.063-21%0.265-81%1.191-96%
Debt To Equity Ratio--0.0530.092-43%0.068-22%0.783-93%0.584-91%
Dividend Per Share----0%-0%-0%-0%
Eps---0.424-0.427+1%-0.463+9%-0.305-28%-0.262-38%
Free Cash Flow Per Share---0.374-0.355-5%-0.295-21%-0.229-39%-0.182-51%
Free Cash Flow To Equity Per Share--1.5630.130+1107%-0.295+119%0.234+567%0.154+913%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---19.955--------
Intrinsic Value_10Y_min---16.989--------
Intrinsic Value_1Y_max---1.294--------
Intrinsic Value_1Y_min---1.271--------
Intrinsic Value_3Y_max---4.426--------
Intrinsic Value_3Y_min---4.214--------
Intrinsic Value_5Y_max---8.206--------
Intrinsic Value_5Y_min---7.570--------
Market Cap65386470.000-5%68449380.00060891982.500+12%71678752.500-5%55989994.800+22%40835692.700+68%
Net Profit Margin---6.856-1.714-75%--100%-9.861+44%-21.678+216%
Operating Margin---7.619-1.905-75%--100%-9.554+25%-22.082+190%
Operating Ratio--7.6191.905+300%-+100%9.618-21%16.513-54%
Pb Ratio1.415-5%1.4821.903-22%1.612-8%-9.682+753%-5.436+467%
Pe Ratio-2.894+4%-3.029-2.743-9%-2.984-1%-3.652+21%-2.812-7%
Price Per Share4.910-5%5.1404.573+12%5.383-5%4.204+22%3.066+68%
Price To Free Cash Flow Ratio-3.284+4%-3.438-3.245-6%-4.615+34%-4.429+29%-3.505+2%
Price To Total Gains Ratio3.072-5%3.216-9.116+383%-19.200+697%-4.337+235%-5.684+277%
Quick Ratio--65.06542.780+52%46.106+41%25.378+156%17.140+280%
Return On Assets---0.116-0.162+40%-0.128+10%-0.228+96%-0.418+260%
Return On Equity---0.122-0.178+46%-0.136+11%-0.544+345%-0.442+262%
Total Gains Per Share--1.5980.140+1040%-0.294+118%0.166+864%0.116+1282%
Usd Book Value--46200000.00033514000.000+38%44818750.000+3%26675687.500+73%16462521.400+181%
Usd Book Value Change Per Share--1.5980.140+1040%-0.294+118%0.166+864%0.116+1282%
Usd Book Value Per Share--3.4692.517+38%3.366+3%2.003+73%1.236+181%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.424-0.427+1%-0.463+9%-0.305-28%-0.262-38%
Usd Free Cash Flow---4977000.000-4722750.000-5%-3933500.000-21%-3047826.400-39%-2424290.467-51%
Usd Free Cash Flow Per Share---0.374-0.355-5%-0.295-21%-0.229-39%-0.182-51%
Usd Free Cash Flow To Equity Per Share--1.5630.130+1107%-0.295+119%0.234+567%0.154+913%
Usd Market Cap65386470.000-5%68449380.00060891982.500+12%71678752.500-5%55989994.800+22%40835692.700+68%
Usd Price Per Share4.910-5%5.1404.573+12%5.383-5%4.204+22%3.066+68%
Usd Profit---5649000.000-5687750.000+1%-6040500.000+7%-4010085.250-29%-3455083.900-39%
Usd Revenue--824000.000206000.000+300%-+100%44324.300+1759%69849.333+1080%
Usd Total Gains Per Share--1.5980.140+1040%-0.294+118%0.166+864%0.116+1282%
 EOD+2 -6MRQTTM+26 -7YOY+23 -105Y+23 -1010Y+24 -9

4.2. Fundamental Score

Let's check the fundamental score of enVVeno Medical Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.894
Price to Book Ratio (EOD)Between0-11.415
Net Profit Margin (MRQ)Greater than0-6.856
Operating Margin (MRQ)Greater than0-7.619
Quick Ratio (MRQ)Greater than165.065
Current Ratio (MRQ)Greater than134.225
Debt to Asset Ratio (MRQ)Less than10.050
Debt to Equity Ratio (MRQ)Less than10.053
Return on Equity (MRQ)Greater than0.15-0.122
Return on Assets (MRQ)Greater than0.05-0.116
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of enVVeno Medical Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.815
Ma 20Greater thanMa 505.084
Ma 50Greater thanMa 1005.508
Ma 100Greater thanMa 2004.887
OpenGreater thanClose4.700
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  -130-6-136-2-1380-138828690
Income Tax Expense  -474-291-765425-340-8-3481,8011,453



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets48,635
Total Liabilities2,435
Total Stockholder Equity46,200
 As reported
Total Liabilities 2,435
Total Stockholder Equity+ 46,200
Total Assets = 48,635

Assets

Total Assets48,635
Total Current Assets46,923
Long-term Assets1,712
Total Current Assets
Cash And Cash Equivalents 3,620
Short-term Investments 42,792
Other Current Assets 511
Total Current Assets  (as reported)46,923
Total Current Assets  (calculated)46,923
+/-0
Long-term Assets
Property Plant Equipment 1,681
Long-term Assets Other 31
Long-term Assets  (as reported)1,712
Long-term Assets  (calculated)1,712
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,371
Long-term Liabilities1,064
Total Stockholder Equity46,200
Total Current Liabilities
Short-term Debt 338
Accounts payable 427
Other Current Liabilities 1,033
Total Current Liabilities  (as reported)1,371
Total Current Liabilities  (calculated)1,798
+/- 427
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,064
Long-term Liabilities  (as reported)1,064
Long-term Liabilities  (calculated)1,064
+/-0
Total Stockholder Equity
Retained Earnings -130,036
Other Stockholders Equity 176,236
Total Stockholder Equity (as reported)46,200
Total Stockholder Equity (calculated)46,200
+/-0
Other
Cash and Short Term Investments 46,412
Common Stock Shares Outstanding 13,317
Current Deferred Revenue-427
Liabilities and Stockholders Equity 48,635
Net Debt -2,218
Net Invested Capital 46,200
Net Working Capital 45,552
Property Plant and Equipment Gross 2,750
Short Long Term Debt Total 1,402



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
> Total Assets 
0
1,783
0
1,732
1,931
2,215
2,800
7,206
5,436
3,559
5,488
7,253
5,751
3,434
2,770
3,733
7,043
10,538
45,055
42,352
59,172
57,699
54,224
49,932
45,456
41,661
36,613
32,086
28,094
48,635
48,63528,09432,08636,61341,66145,45649,93254,22457,69959,17242,35245,05510,5387,0433,7332,7703,4345,7517,2535,4883,5595,4367,2062,8002,2151,9311,73201,7830
   > Total Current Assets 
0
393
0
372
549
170
447
6,109
4,364
2,837
2,946
4,630
3,060
1,424
840
1,785
5,978
9,569
44,166
41,439
58,207
55,040
51,650
37,760
40,708
39,436
34,519
30,108
26,217
46,923
46,92326,21730,10834,51939,43640,70837,76051,65055,04058,20741,43944,1669,5695,9781,7858401,4243,0604,6302,9462,8374,3646,10944717054937203930
       Cash And Cash Equivalents 
0
57
0
16
311
78
309
5,942
4,189
2,741
2,753
4,465
2,943
1,307
720
1,564
5,629
9,335
43,837
41,039
57,897
54,728
51,338
9,070
2,895
4,555
2,273
4,714
4,946
3,620
3,6204,9464,7142,2734,5552,8959,07051,33854,72857,89741,03943,8379,3355,6291,5647201,3072,9434,4652,7532,7414,1895,94230978311160570
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,413
37,432
34,489
31,934
25,042
20,751
42,792
42,79220,75125,04231,93434,48937,43228,41300000000000000000000000
       Net Receivables 
0
190
0
199
106
35
31
29
28
32
27
0
0
0
0
0
0
0
0
0
0
0
0
38
0
0
0
0
0
0
0000003800000000000027322829313510619901900
       Other Current Assets 
0
56
0
157
132
58
107
138
147
64
167
165
117
117
120
221
349
234
329
400
310
312
312
239
381
392
312
352
520
511
51152035231239238123931231231040032923434922112011711716516764147138107581321570560
   > Long-term Assets 
0
1,390
0
1,360
1,382
2,044
2,353
1,097
1,072
722
2,542
2,623
2,691
2,010
1,926
1,949
1,065
969
889
913
965
2,659
2,574
12,172
4,748
2,225
2,094
1,978
1,877
1,712
1,7121,8771,9782,0942,2254,74812,1722,5742,6599659138899691,0651,9491,9262,0102,6912,6232,5427221,0721,0972,3532,0441,3821,36001,3900
       Property Plant Equipment 
0
29
0
20
18
24
21
19
25
26
1,055
1,156
1,243
1,170
1,086
1,109
1,035
939
859
878
911
2,605
2,543
2,435
2,316
2,194
2,063
1,947
1,811
1,681
1,6811,8111,9472,0632,1942,3162,4352,5432,6059118788599391,0351,1091,0861,1701,2431,1561,055262519212418200290
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,706
2,398
0
0
0
0
0
000002,3989,70600000000000000000000000
       Intangible Assets 
0
1,233
0
0
1,140
1,109
1,079
1,048
1,017
666
647
628
608
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000006086286476661,0171,0481,0791,1091,140001,2330
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
30
30
30
35
54
54
31
31
0
31
0
0
0
0
000031031315454353030300400000000000000
> Total Liabilities 
0
6,002
0
8,089
10,092
13,345
18,541
2,595
1,893
1,523
2,623
2,601
2,667
2,444
2,784
3,364
2,248
3,440
2,043
1,478
1,118
3,295
2,907
3,374
2,785
2,932
2,484
3,274
3,179
2,435
2,4353,1793,2742,4842,9322,7853,3742,9073,2951,1181,4782,0433,4402,2483,3642,7842,4442,6672,6012,6231,5231,8932,59518,54113,34510,0928,08906,0020
   > Total Current Liabilities 
0
2,067
0
3,523
5,526
8,175
13,370
2,595
1,893
1,523
1,839
1,883
2,016
1,876
2,253
2,953
1,915
3,186
1,874
1,393
1,118
1,580
1,270
1,816
1,304
1,530
1,167
2,067
2,031
1,371
1,3712,0312,0671,1671,5301,3041,8161,2701,5801,1181,3931,8743,1861,9152,9532,2531,8762,0161,8831,8391,5231,8932,59513,3708,1755,5263,52302,0670
       Short-term Debt 
0
633
0
1,039
1,669
2,619
4,697
26
28
27
271
271
271
289
259
614
621
627
633
639
332
291
297
303
308
314
320
352
331
338
3383313523203143083032972913326396336276216142592892712712712728264,6972,6191,6691,03906330
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
313
313
313
313
0
0
0
0
0
0
0
0
0
0
00000000003133133133130000000000000000
       Accounts payable 
0
542
0
791
766
1,451
1,502
1,361
1,223
1,077
1,096
1,197
1,211
1,221
1,398
1,567
974
1,390
709
309
394
560
557
1,034
501
648
380
1,304
1,235
427
4271,2351,3043806485011,0345575603943097091,3909741,5671,3981,2211,2111,1971,0961,0771,2231,3611,5021,45176679105420
       Other Current Liabilities 
0
551
0
1,289
2,461
4,001
7,067
1,159
607
386
439
382
500
333
563
739
288
1,136
532
412
359
60
416
479
495
568
467
1,715
1,700
1,033
1,0331,7001,715467568495479416603594125321,1362887395633335003824393866071,1597,0674,0012,4611,28905510
   > Long-term Liabilities 
0
3,936
0
4,566
4,566
5,171
5,171
1,185
635
413
784
718
652
568
532
411
332
254
169
85
0
1,715
1,637
1,558
1,481
1,402
1,317
1,207
1,148
1,064
1,0641,1481,2071,3171,4021,4811,5581,6371,7150851692543324115325686527187844136351,1855,1715,1714,5664,56603,9360
> Total Stockholder Equity
0
-4,219
0
-6,357
-8,161
-11,130
-15,741
4,611
3,542
2,036
2,865
4,652
3,084
990
-15
369
4,795
7,098
43,012
40,874
58,054
54,404
51,317
46,558
42,671
38,729
34,129
28,812
24,915
46,200
46,20024,91528,81234,12938,72942,67146,55851,31754,40458,05440,87443,0127,0984,795369-159903,0844,6522,8652,0363,5424,611-15,741-11,130-8,161-6,3570-4,2190
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000
   Retained Earnings Total Equity0000-106,5200000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
145,249
0
0
0
0
0000145,2490000000000000000000000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
0
23,509
0
23,784
24,235
24,389
24,527
49,923
50,323
50,599
53,001
56,734
56,981
57,178
57,333
59,344
65,744
72,421
111,108
111,348
130,918
136,255
138,498
140,801
143,011
145,249
147,041
148,198
149,302
176,236
176,236149,302148,198147,041145,249143,011140,801138,498136,255130,918111,348111,10872,42165,74459,34457,33357,17856,98156,73453,00150,59950,32349,92324,52724,38924,23523,784023,5090



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-546
Gross Profit-546-546
 
Operating Income (+$)
Gross Profit-546
Operating Expense-24,692
Operating Income-25,238-25,238
 
Operating Expense (+$)
Research Development13,583
Selling General Administrative12,021
Selling And Marketing Expenses0
Operating Expense24,69225,604
 
Net Interest Income (+$)
Interest Income172
Interest Expense-0
Other Finance Cost-0
Net Interest Income172
 
Pretax Income (+$)
Operating Income-25,238
Net Interest Income172
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-23,516-26,960
EBIT - interestExpense = -25,238
-23,516
-23,516
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-25,238-23,516
Earnings Before Interest and Taxes (EBITDA)-24,692
 
After tax Income (+$)
Income Before Tax-23,516
Tax Provision-0
Net Income From Continuing Ops-24,047-23,516
Net Income-23,516
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses25,238
Total Other Income/Expenses Net1,722-172
 

Technical Analysis of Envveno
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Envveno. The general trend of Envveno is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Envveno's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of enVVeno Medical Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.822 < 5.32 < 5.43.

The bearish price targets are: 4.64 > 4.06 > 3.8.

Tweet this
enVVeno Medical Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of enVVeno Medical Corp. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

enVVeno Medical Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of enVVeno Medical Corp. The current macd is -0.21254874.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Envveno price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Envveno. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Envveno price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
enVVeno Medical Corp Daily Moving Average Convergence/Divergence (MACD) ChartenVVeno Medical Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of enVVeno Medical Corp. The current adx is 23.93.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Envveno shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
enVVeno Medical Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of enVVeno Medical Corp. The current sar is 5.36640731.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
enVVeno Medical Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of enVVeno Medical Corp. The current rsi is 42.82. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
enVVeno Medical Corp Daily Relative Strength Index (RSI) ChartenVVeno Medical Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of enVVeno Medical Corp. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Envveno price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
enVVeno Medical Corp Daily Stochastic Oscillator ChartenVVeno Medical Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of enVVeno Medical Corp. The current cci is -102.44061814.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
enVVeno Medical Corp Daily Commodity Channel Index (CCI) ChartenVVeno Medical Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of enVVeno Medical Corp. The current cmo is -12.98347123.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
enVVeno Medical Corp Daily Chande Momentum Oscillator (CMO) ChartenVVeno Medical Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of enVVeno Medical Corp. The current willr is -61.79775281.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Envveno is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
enVVeno Medical Corp Daily Williams %R ChartenVVeno Medical Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of enVVeno Medical Corp.

enVVeno Medical Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of enVVeno Medical Corp. The current atr is 0.30347168.

enVVeno Medical Corp Daily Average True Range (ATR) ChartenVVeno Medical Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of enVVeno Medical Corp. The current obv is -1,916,095.

enVVeno Medical Corp Daily On-Balance Volume (OBV) ChartenVVeno Medical Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of enVVeno Medical Corp. The current mfi is 38.49.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
enVVeno Medical Corp Daily Money Flow Index (MFI) ChartenVVeno Medical Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for enVVeno Medical Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

enVVeno Medical Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of enVVeno Medical Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.815
Ma 20Greater thanMa 505.084
Ma 50Greater thanMa 1005.508
Ma 100Greater thanMa 2004.887
OpenGreater thanClose4.700
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Envveno with someone you think should read this too:
  • Are you bullish or bearish on Envveno? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Envveno? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about enVVeno Medical Corp

I send you an email if I find something interesting about enVVeno Medical Corp.


Comments

How you think about this?

Leave a comment

Stay informed about enVVeno Medical Corp.

Receive notifications about enVVeno Medical Corp in your mailbox!